These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18215285)

  • 1. l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T; Xu T
    Behav Brain Funct; 2008 Jan; 4():3. PubMed ID: 18215285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2011 Mar; 7():6. PubMed ID: 21450079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2006 Dec; 2():41. PubMed ID: 17173664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype.
    Sagvolden T; Dasbanerjee T; Zhang-James Y; Middleton F; Faraone S
    Behav Brain Funct; 2008 Dec; 4():56. PubMed ID: 19046438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.
    Jordan CJ; Taylor DM; Dwoskin LP; Kantak KM
    Behav Brain Res; 2016 Jan; 297():165-79. PubMed ID: 26467602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.
    Jordan CJ; Lemay C; Dwoskin LP; Kantak KM
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3891-3903. PubMed ID: 27600990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes.
    Sagvolden T; Johansen EB; Aase H; Russell VA
    Behav Brain Sci; 2005 Jun; 28(3):397-419; discussion 419-68. PubMed ID: 16209748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA; de Villiers AS; Sagvolden T; Lamm MC; Taljaard JJ
    Brain Res Bull; 2000 Sep; 53(2):187-92. PubMed ID: 11044595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder.
    Boix F; Qiao SW; Kolpus T; Sagvolden T
    Behav Brain Res; 1998 Jul; 94(1):153-62. PubMed ID: 9708846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes.
    Johansen EB; Aase H; Meyer A; Sagvolden T
    Behav Brain Res; 2002 Mar; 130(1-2):37-45. PubMed ID: 11864716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
    Soeters HS; Howells FM; Russell VA
    Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task.
    Bizot JC; Cogrel N; Massé F; Chauvin V; Brault L; David S; Trovero F
    Psychopharmacology (Berl); 2015 Sep; 232(17):3269-86. PubMed ID: 26037943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced visual responses in the superior colliculus in an animal model of attention-deficit hyperactivity disorder and their suppression by D-amphetamine.
    Clements KM; Devonshire IM; Reynolds JN; Overton PG
    Neuroscience; 2014 Aug; 274():289-98. PubMed ID: 24905438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
    Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
    Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glutamate-stimulated norepinephrine release from prefrontal cortex slices of spontaneously hypertensive rats.
    Russell VA; Wiggins TM
    Metab Brain Dis; 2000 Dec; 15(4):297-304. PubMed ID: 11383554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically determined differences in noradrenergic function: The spontaneously hypertensive rat model.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2016 Jun; 1641(Pt B):291-305. PubMed ID: 26612520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.